New hope for pancreatic cancer: drug combo aims to shrink tumors
NCT ID NCT07578337
First seen May 13, 2026 · Last updated May 13, 2026
Summary
This study tests whether adding a hedgehog inhibitor (NLM-001) and two immunotherapy drugs (botensilimab and balstilimab) to standard chemotherapy can shrink tumors better than chemotherapy alone in people with advanced pancreatic cancer that hasn't been treated yet. About 40 adults with stage IV pancreatic cancer will take part. The goal is to see if the new combination improves response rates while keeping side effects manageable.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Complexo Hospitalario Universitario de Santiago
Santiago de Compostela, La Coruña, Spain
Contact
Contact
-
Hospital Clínic Barcelona
Barcelona, Barcelona, Spain
Contact
Contact
-
Hospital Universitario Marqués de Valdecilla
Santander, Cantabria, Spain
Contact
Contact
-
Hospital Universitario Miguel Servet
Zaragoza, Aragon, Spain
Contact
Contact
-
Hospital Universitario Virgen de la Victoria
Málaga, Málaga, Spain
Contact
Contact
-
Hospital Universitario de Donostia
San Sebastián, Gipuzkoa, Spain
Contact
Contact
Conditions
Explore the condition pages connected to this study.